October 30, 2012 — Fractional flow reserve (FFR)-guided treatment was shown to be cost effective for guiding coronary ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
October 30, 2012
October 30, 2012 — Elixir Medical Corp. said enrollment is complete in its 120-patient, pivotal clinical trial ...
October 30, 2012
October 29, 2012 — Brainlab released Buzz Digital OR, which is designed to aid information integration for the surgical ...
October 29, 2012Sponsored Content
Feature | Thrombectomy Devices
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
June 01, 2026
October 26, 2012 — Covidien announced final 12-month results from its DEFINITIVE LE (Determination of Effectiveness of ...
October 26, 2012
October 22, 2012 — W. L. Gore & Associates announced that the U.S. Food and Drug Administration (FDA) has approved the ...
October 22, 2012
October 19, 2012 — The 24th Transcatheter Cardiovascular Therapeutics (TCT) conference, sponsored by the Cardiovascular ...
October 19, 2012Sponsored Content
Blog | Contrast Media Injectors
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
August 22, 2023
October 19, 2012 — Volcano Corp., a developer and manufacturer of precision-guided therapy tools designed to enhance the ...
October 19, 2012
October 19, 2012 — Edwards Lifesciences announced today it received approval from the United States Food and Drug ...
October 19, 2012
October 18, 2012 – Infraredx Inc. and Royal Philips Electronics announced they have signed a joint development and ...
October 18, 2012Sponsored Content
Blog | Enterprise Imaging
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
August 10, 2023
October 17, 2012 — AngioDynamics entered into a definitive agreement to acquire all the outstanding capital stock of ...
October 17, 2012October 16, 2012 — Proteon Therapeutics Inc. has initiated enrollment in a Phase 1 clinical study of its lead product ...
October 16, 2012
October 12, 2012 — Boston Scientific announced it has enrolled the first patient in the REPRISE II clinical trial to ...
October 12, 2012Sponsored Content
Case Study | Baylor Scott and White Heart Hospital
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
May 05, 2023October 11, 2012 — Spectranetics Corp. announced the U.S. market launch of the Tapas catheter at the 2012 Vascular ...
October 11, 2012
October 11, 2012 — Boston Scientific Corporation has begun the U.S. and European launch of its Victory guidewire ...
October 11, 2012
October 4, 2012 — Researchers at the University of Maryland School of Medicine, who are exploring novel ways to treat ...
October 04, 2012